|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2001-8-2
|
|
pubmed:abstractText |
Tolterodine is a bladder-selective antimuscarinic agent designed for the treatment of overactive bladder. Traditional antimuscarinic therapies are poorly tolerated due to a high incidence of anticholinergic adverse events and consequently few patients remain on long term therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1170-229X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
551-60
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11482747-Adolescent,
pubmed-meshheading:11482747-Adult,
pubmed-meshheading:11482747-Aged,
pubmed-meshheading:11482747-Aged, 80 and over,
pubmed-meshheading:11482747-Benzhydryl Compounds,
pubmed-meshheading:11482747-Cresols,
pubmed-meshheading:11482747-Female,
pubmed-meshheading:11482747-Humans,
pubmed-meshheading:11482747-Male,
pubmed-meshheading:11482747-Middle Aged,
pubmed-meshheading:11482747-Muscarinic Antagonists,
pubmed-meshheading:11482747-Phenylpropanolamine,
pubmed-meshheading:11482747-Urinary Bladder Diseases
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine.
|
|
pubmed:affiliation |
Bristol Urological Institute, Southmead Hospital, Westbury-on-Trym, England. paul_abrams@bui.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
